Colonoscopy

Colonoscopy has been studied in 176 papers since 2003: 11 trials and 85 observational studies in people, 62 reviews; 123 in the past year. The newest paper, Nov 18, 2026: “National guidelines for colorectal cancer screening in Saudi Arabia: Recommendations from the multi-society guideline development task force”.

Intervention

176 papers study it53 findingsUpdated

MeSH

16 new papers in 30 daysSee all 176 papers on colonoscopy

At a glance

Colonoscopy is linked with lower mortality in human studies from independent labs, but a propensity-matched screening analysis finds no clear mortality link. Colorectal cancer links range from lower to higher risk or no clear association across screening and surveillance studies; independent labs also report perforation associations. Two of 10 papers declare company ties; some authors work at Samsung companies.

53 findings in 36 papers from 2005 to 2026, 14 of them since April 2026

Independent labs found the same change in people. 17 independent labs in 10 countries.

“The observed reductions in CRC-related mortality and CRC incidence, which were consistent across both screening strategies, were independent of sex or age.”
Sex- and Age-Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post-Analysis of the COLONPREV StudyUnited European gastroenterology journal2026doi:10.1002/ueg2.70169

7 of its findings point the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 17 independent labs in 10 countries
  • 7 findings against
  • Funders: National Cancer Institute and others
  • 6 of 32 findings with company ties
  • Human trial11
  • Humans85
  • In silico18

Studies in people

1 study gave colonoscopy to people and measured what changed.

What changedDesignPeopleSource

down: Lowers the risk of colorectal cancer

Randomized trialBoth50-69 yearsMidlife adults; Older adults; healthy adultsUnited European gastroenterology journal, Feb 20, 2026

What did studies of colonoscopy find?

7

Studies of colonoscopy measured 7 outcomes; the most studied are mortality (6 studies), colorectal cancer (5) and colorectal cancer mortality (3).

Mortality

downin humans4no changein humans1downin silico1−61%HR 1.01

6 studies
  1. Colonoscopy was not clearly linked with mortality in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 1.01, 95% CI 0.97–1.05).

    “Five-year all-cause mortality was unchanged (HR 1.01 [0.97-1.05]; p = 0.741).”

    HumansPropensity-matched adults with a colorectal cancer screening encounterscreening5 years

    Colonoscopy linked to more cancer detection in older adults

    JGH open : an open access journal of gastroenterology and hepatology

  2. Colonoscopy is linked with lower mortality in humans (surveillance at a mean interval of ≤3 years).

    “Surveillance at a mean interval of ≤3 years (n=3028) was associated with a decrease in CRC-specific and all-cause mortality”

    Humanssurveillance at a mean interval of ≤3 yearsn = 3,028

    Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022

    Gut

  3. Colonoscopy decreases mortality in humans.

    “polypectomy substantially reduces CRC incidence and mortality.”

    Review

    Screening for Colorectal Cancer with Colonoscopy

    Gastrointestinal endoscopy clinics of North America

  4. Colonoscopy decreases mortality in silico (95.3% (95% CI = 93.8% - 96.5%)).

    “and 95.3% (95% CI = 93.8% - 96.5%) of CRC mortality.”

    In silico

    Model predicts a shift in colon cancer origins with screening

    Journal of the National Cancer Institute

  5. Colonoscopy decreases mortality in humans (>30%).

    “Colonoscopy screening, proven globally to reduce mortality by over 30%, represents an underutilized intervention”

    Review

    Strengthening colonoscopy screening in primary care: A preventive imperative before the coming surge

    Journal of family medicine and primary care

  6. Colonoscopy decreases mortality in humans (61%).

    “Colonoscopy lowers mortality by 61%”

    Review

    Current Perspectives on Colorectal Cancer Screening and Surveillance in the Geriatric Population

    Current gastroenterology reports

Colorectal cancer

downin silico2no changein humans1downin humans1downin reviews1−26%

5 studies
  1. Colonoscopy was not clearly linked with colorectal cancer in humans (surveillance at a mean interval of ≤3 years).

    “without an associated change in total CRC incidence, even after multivariate adjustment”

    Humanssurveillance at a mean interval of ≤3 yearsn = 3,028

    Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022

    Gut

  2. Colonoscopy decreases colorectal cancer in silico (simulated relative to no screening) (26%).

    “Relative to no screening, colonoscopy and FIT reduced late-stage diagnoses by 26% and 25%, respectively, versus 20%-32% for annual MCED screening.”

    In silicosimulated relative to no screening

    Should Multi-Cancer Early Detection Testing Replace Guideline-Recommended Colorectal Cancer Screening? A Comparative Modeling Analysis

    medRxiv : the preprint server for health sciencesPreprint

  3. Colonoscopy prevents colorectal cancer in humans (through precancerous lesion detection and removal).

    “Colonoscopy remains the most comprehensive screening modality, enabling the detection and removal of precancerous lesions, thereby preventing the development of CRC.”

    Reviewthrough precancerous lesion detection and removal

    Best choice for colorectal cancer screening at the population level: fecal immunochemical test, stool DNA test, or colonoscopy

    Clinical endoscopy

  4. Colonoscopy prevents colorectal cancer in silico (93.9% (95% CI = 92.0% - 94.3%)).

    “Screening was predicted to prevent 93.9% (95% CI = 92.0% - 94.3%) of CRC”

    In silico

    Model predicts a shift in colon cancer origins with screening

    Journal of the National Cancer Institute

  5. Colonoscopy prevents colorectal cancer.

    “Colonoscopy prevents colorectal cancer through polyp detection and resection.”

    Review

    Ensuring High-Quality Colonoscopy: A Review

    Gastrointestinal endoscopy clinics of North America

More on Colorectal cancer

Colorectal cancer mortality

downin humans2downin silico1

3 studies
  1. Colonoscopy decreases colorectal cancer mortality in humans.

    “evidence supports colonoscopy's ability to reduce population-wide colorectal cancer mortality”

    Review

    AGA Clinical Practice Update on Surveillance of Metaplastic and Premalignant Conditions of the Esophagus and Colorectum in Older Adults: Expert Review

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

  2. Colonoscopy decreases colorectal cancer mortality in Lynch syndrome.

    “colonoscopic surveillance in LS reliably reduces CRC mortality”

    Reviewin Lynch syndrome

    Colonoscopy surveillance in Lynch syndrome: what it prevents and what it does not

    Journal of medical genetics

  3. Colonoscopy decreases colorectal cancer mortality in silico (healthy) (42 people needed to screen to prevent one cancer-related death).

    “One cancer-related death would be prevented by screening 42 healthy men aged 70-74 years with colonoscopy”

    In silicohealthyevery 10 yearsmales

    Comparing risks and benefits of colorectal cancer screening in elderly patients

    Gastroenterology

Lifespan

upin silico1

1 study
  1. Colonoscopy improves lifespan in silico (colonoscopy at age 40/50/60/70) (449 LYG per 1000 individuals).

    “The most effective colonoscopy-based screening strategy is colonoscopy at age 40/50/60/70 (449 LYG per 1000 individuals)”

    In silicocolonoscopy at age 40/50/60/70

    Evidence-based decision analysis guiding clinical guidelines for an organized population-based screening for colorectal cancer

    Best practice & research. Clinical gastroenterology

Death or overnight hospitalization

no changein humans1

1 study
  1. Colonoscopy was not clearly linked with death or overnight hospitalization in humans (narrow analysis) (RD = 0% (95% CI, -0.36% to 0.35%)).

    “Screening colonoscopy patients had a 1.04% (95% CI, 0.74%-1.34%) risk of death or hospitalization within 30 days in the narrow analysis, similar to those with FIT [RD = 0% (95% CI, -0.36% to 0.35%)]”

    Humansnarrow analysis30 days

    Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Lifetime gained

no changein humans1

1 study
  1. Colonoscopy showed no clear effect on lifetime gained in humans (37 days (95% CI, -146 to 146 days)).

    “colonoscopy (37 days; 95% CI, -146 to 146 days)”

    Review10 years follow-up

    Estimated Lifetime Gained With Cancer Screening Tests: A Meta-Analysis of Randomized Clinical Trials

    JAMA internal medicine

Quality-adjusted life-years gained

upin silico1

1 study
  1. Colonoscopy improves quality-adjusted life-years gained in silico (unscreened elderly persons with no comorbid conditions).

    “Screening with colonoscopy was indicated up to age 83 years, sigmoidoscopy was indicated at age 84 years, and FIT was indicated at ages 85 and 86 years.”

    In silicounscreened elderly persons with no comorbid conditions

    Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis

    Annals of internal medicine

What is colonoscopy linked with?

20

Studies link colonoscopy with 20 measures, most often colorectal cancer (9 studies), colorectal polyp detection (2) and gastrointestinal bleeding (2).

Colorectal cancer

downin humans7upin humans2

9 studies
  1. Colonoscopy lowers the risk of colorectal cancer in humans (healthy adults).

    “The observed reductions in CRC-related mortality and CRC incidence, which were consistent across both screening strategies, were independent of sex or age.”

    Human trialhealthy adults

    Sex- and Age-Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post-Analysis of the COLONPREV Study

    United European gastroenterology journal

  2. Colonoscopy is linked with a higher risk of colorectal cancer in humans (colonoscopic surveillance at a mean interval of ≤2 years).

    “Colonoscopic surveillance at a mean interval of ≤2 years (n=1569) was associated with an increase in total CRC incidence.”

    Humanscolonoscopic surveillance at a mean interval of ≤2 yearsn = 1,569

    Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022

    Gut

  3. Colonoscopy is linked with a lower risk of colorectal cancer in humans (aHR 0.75, 95% CI 0.66-0.84).

    “Colonoscopy was associated with a significantly reduced CRC risk among adults aged 75 to 79 years (aHR, 0.75; 95% CI, 0.66-0.84)”

    Humans

    Colonoscopy linked to lower colorectal cancer risk at ages 75–79

    Gastrointestinal endoscopy

  4. Colonoscopy is linked with a lower risk of colorectal cancer in humans (5.5 fewer cases (95% confidence interval: 1.44-9.56) per 1000 person-years, corresponding to a 45.5% reduction).

    “After 10 years of follow-up, a reduction was seen between the groups from 12.1 to 6.6 cases per 1000 person-years, equivalent to 5.5 fewer cases (95% confidence interval: 1.44-9.56) per 1000 person-years”

    Humans10 yearsn = 2,773

    Effect of offering colonoscopy at the faecal immunochemical test (FIT) positivity threshold: a regression discontinuity analysis in older adults

    International journal of epidemiology

  5. Colonoscopy is linked with a lower risk of colorectal cancer in humans after positive FOBT (SIR 0.52 (95% CI, 0.39-0.68)).

    “Individuals with a negative screening colonoscopy result had a significantly lower observed CRC incidence (SIR, 0.52; 95% CI, 0.39-0.68) relative to the general population”

    Humansafter positive FOBTcolorectaln = 8,433

    Colorectal Cancer Risk With Negative Colonoscopy or Nonadherence After Positive FOBT Screening

    JAMA network open

  6. Colonoscopy is associated with colorectal cancer in humans (10 years after negative colonoscopy) (1.29% (95% CI, 1.02%-1.61%) at 8 years).

    “with a cumulative incidence of 0.39% [95% CI, 0.31%-0.48%) at 2 years that increased to 1.29% (95% CI, 1.02%-1.61%) at 8 years.”

    Humans10 years after negative colonoscopy8 years

    Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

  7. Colonoscopy lowers the risk of colorectal cancer in individuals with serrated polyposis syndrome.

    “frequent surveillance colonoscopy is recommended to decrease incident CRC.”

    Reviewin individuals with serrated polyposis syndrome

    Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

    Gastrointestinal endoscopy

  8. Colonoscopy lowers the risk of colorectal cancer in humans (reducing CRC incidence and mortality by up to 77% and 53%, respectively) (up to 77% and 53%).

    “reducing CRC incidence and mortality by up to 77% and 53%, respectively”

    Reviewreducing CRC incidence and mortality by up to 77% and 53%, respectively

    Artificial Intelligence-Assisted Colonoscopy for Colorectal Lesion Detection: Current Evidence, Challenges, and Future Directions

    Journal of clinical medicine

  9. Colonoscopy lowers the risk of colorectal cancer in humans.

    “polypectomy substantially reduces CRC incidence and mortality.”

    Review

    Screening for Colorectal Cancer with Colonoscopy

    Gastrointestinal endoscopy clinics of North America

More on Colorectal cancer

Colorectal polyp detection

upin humans2OR 2.27

2 studies
  1. Colonoscopy is associated with colorectal polyp detection in humans (Compared with symptomatic diagnostic colonoscopy; adjusted for age category and sex) (40.7% vs. 27.9%; adjusted OR 2.27 (95% CI 1.72–3.01)).

    “Screening-indication colonoscopy showed higher overall polyp (40.7% vs. 27.9%)”

    HumansCompared with symptomatic diagnostic colonoscopy; adjusted for age category and sexscreening-indicationn = 1,208

    Screening or Symptoms? Colonoscopy Indication–Based Differences in Colorectal Polyp and Neoplastic Lesion Detection

    Frontiers in surgery

  2. Colonoscopy is associated with colorectal polyp detection in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 1.88, 95% CI 1.82–1.95).

    “Colonoscopy increased polyp detection (HR 4.43 [95% CI 4.15-4.73] at 30 days; 1.88 [1.82-1.95] at 5 years)”

    HumansPropensity-matched adults with a colorectal cancer screening encounterscreening5 years

    Colonoscopy linked to more cancer detection in older adults

    JGH open : an open access journal of gastroenterology and hepatology

Gastrointestinal bleeding

downin humans1upin humans1HR 0.9

2 studies
  1. Colonoscopy is associated with gastrointestinal bleeding in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 0.90, 95% CI 0.84–0.97).

    “gastrointestinal bleeding fell at 1 year (HR 0.90 [0.84-0.97]; p = 0.004).”

    HumansPropensity-matched adults with a colorectal cancer screening encounterscreening1 year

    Colonoscopy linked to more cancer detection in older adults

    JGH open : an open access journal of gastroenterology and hepatology

  2. Colonoscopy is linked with a higher risk of gastrointestinal bleeding in humans (0.18% (95% CI, 0.09%-0.35%)).

    “Patients undergoing screening colonoscopy (N = 4,435) had a higher 10-day cumulative incidence of gastrointestinal bleeding {0.18% [95% confidence interval (CI), 0.09%-0.35%]} and perforation [0.09% (95% CI, 0.03%-0.23%)]”

    Humans10 days

    Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on Gastrointestinal bleeding

Perforation

upin humans2HR 1.29

2 studies
  1. Colonoscopy is associated with perforation in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 1.29, 95% CI 1.02–1.63).

    “Perforation rose at 5 years (HR 1.29 [1.02-1.63]; p = 0.033)”

    HumansPropensity-matched adults with a colorectal cancer screening encounterscreening5 years

    Colonoscopy linked to more cancer detection in older adults

    JGH open : an open access journal of gastroenterology and hepatology

  2. Colonoscopy is linked with a higher risk of perforation in humans (0.09% (95% CI, 0.03%-0.23%)).

    “Patients undergoing screening colonoscopy (N = 4,435) had a higher 10-day cumulative incidence of gastrointestinal bleeding {0.18% [95% confidence interval (CI), 0.09%-0.35%]} and perforation [0.09% (95% CI, 0.03%-0.23%)]”

    Humans10 days

    Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on Perforation

Mortality

mixedin humans1downin humans1HR 0.86

2 studies
  1. Colonoscopy is associated with mortality in humans (Complete versus incomplete colonoscopy diagnostic process).

    “death (p < 0.001) between patients who had a complete colonoscopy diagnostic process and those who did not.”

    HumansComplete versus incomplete colonoscopy diagnostic process

    The impact of incomplete colonoscopies: a single-centre retrospective study

    Canadian journal of surgery. Journal canadien de chirurgie

  2. Colonoscopy is linked with a lower risk of mortality in humans (comparing ever- to never-screening) (HR 0.86, 95% CI 0.75-0.99).

    “hazard ratios (95% confidence intervals) for all-cause mortality comparing ever- to never-screening were 0.86 (0.75-0.99) for young individuals”

    Humanscomparing ever- to never-screening

    Colonoscopic Screening and Risk of All-Cause and Colorectal Cancer Mortality in Young and Older Individuals

    Cancer research and treatment

Colorectal cancer mortality

downin humans1upin humans1HR 0.52

2 studies
  1. Colonoscopy is linked with a lower risk of colorectal cancer mortality in humans (comparing ever- to never-screening) (HR 0.52, 95% CI 0.31-0.87).

    “0.52 (0.31-0.87) for those aged ≥ 45 years.”

    Humanscomparing ever- to never-screening

    Colonoscopic Screening and Risk of All-Cause and Colorectal Cancer Mortality in Young and Older Individuals

    Cancer research and treatment

  2. Colonoscopy is associated with colorectal cancer mortality in humans (10 years after negative colonoscopy) (0.46% (95% CI, 0.30%-0.70%) at 8 years).

    “Cumulative mortality from colorectal cancer was 0.04% (95% CI, 0.02%-0.08%) at 2 years and 0.46% (95% CI, 0.30%-0.70%) at 8 years.”

    Humans10 years after negative colonoscopy8 years

    Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Colorectal adenocarcinoma detection

downin humans1OR 0.15

1 study
  1. Colonoscopy is associated with colorectal adenocarcinoma detection in humans (Compared with symptomatic diagnostic colonoscopy; adjusted for age category and sex) (0.2% vs. 1.9%; Firth adjusted OR 0.15 (95% CI 0.02–0.61)).

    “symptomatic diagnostic examinations showed greater detection of conventional adenomas, large polyps, advanced precursor lesions, and adenocarcinoma.”

    HumansCompared with symptomatic diagnostic colonoscopy; adjusted for age category and sexscreening-indicationn = 1,208

    Screening or Symptoms? Colonoscopy Indication–Based Differences in Colorectal Polyp and Neoplastic Lesion Detection

    Frontiers in surgery

Colorectal cancer detection

upin humans1HR 1.78

1 study
  1. Colonoscopy is associated with colorectal cancer detection in humans (Propensity-matched adults with a colorectal cancer screening encounter) (HR 1.78, 95% CI 1.59–1.98).

    “and colorectal cancer detection (4.56 [3.62-5.74]; 1.78 [1.59-1.98]; all p ≤ 0.003).”

    HumansPropensity-matched adults with a colorectal cancer screening encounterscreening5 years

    Colonoscopy linked to more cancer detection in older adults

    JGH open : an open access journal of gastroenterology and hepatology

Colonic perforation

upin reviews1

1 study
  1. Colonoscopy raises the risk of colonic perforation (universal polypectomy strategy).

    “which removes more pseudodisease and incurs excess risk of colonic perforation without benefit.”

    Reviewuniversal polypectomy strategy

    CT Colonography: Where Are We with Colorectal Cancer Screening?

    Radiographics : a review publication of the Radiological Society of North America, Inc

More on Colonic perforation

Colorectal neoplasia

upin humans1+56%

1 study
  1. Colonoscopy is associated with colorectal neoplasia in humans (56.1%).

    “Colorectal neoplasia was identified at colonoscopy in over half of participants (56.1%)”

    Humansn = 4,754

    Baseline characteristics of participants recruited into the COLO-COHORT study: a UK-wide resource for colorectal cancer prevention

    BMJ open gastroenterology

More on Colorectal neoplasia

All 20

What acts on colonoscopy?

1

Studies name Multivariable fractional-polynomial interaction model as acting on colonoscopy.

Multivariable fractional-polynomial interaction model

downin humans1

1 study
  1. multivariable fractional-polynomial interaction model is linked with lower colonoscopy in humans (12% risk cutoff) (reducing colonoscopy volume by 48.4%).

    “Using a 12% risk cutoff, one ACN was detected for every three colonoscopies, reducing colonoscopy volume by 48.4%.”

    Humans12% risk cutoffn = 1,374

    Risk-Based Colonoscopy Prioritization Model for Advanced Colorectal Neoplasia: Development and Validation Study

    Journal of gastroenterology and hepatology

Funding

26 grants since 2010

National Cancer Institute$21.9MUS Department of Veterans AffairsNational Institute of Diabetes and Digestive and Kidney Diseases$1.7M

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    In human cohorts, colonoscopy associates with colorectal neoplasia detection. Reviews indicate it reduces colorectal cancer risk, including in individuals with serrated polyposis syndrome, while universal polypectomy strategies raise the risk of colonic perforation.

  2. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 15Feb 2026: 24Mar 2026: 15Apr 2026: 2May 2026: 2Jun 2026: 4Jul 2026: 10Aug 2026: 13Sep 2026: 15Oct 2026: 13Nov 2026: 8123 papers in 12 months

See all 176 papers on colonoscopy